131 related articles for article (PubMed ID: 29232585)
1. Synthesis of new triterpenic monomers and dimers as potential antiproliferative agents and their molecular docking studies.
Saeed A; Hussain H; Shamraiz U; Rehman NU; Khan HY; Badshah A; Heller L; Csuk R; Ali M; Khan A; Al-Harrasi A
Eur J Med Chem; 2018 Jan; 143():948-957. PubMed ID: 29232585
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new boswellic acid derivatives as potential antiproliferative agents.
Shamraiz U; Hussain H; Ur Rehman N; Al-Shidhani S; Saeed A; Khan HY; Khan A; Fischer L; Csuk R; Badshah A; Al-Rawahi A; Hussain J; Al-Harrasi A
Nat Prod Res; 2020 Jul; 34(13):1845-1852. PubMed ID: 30691289
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of ring A modified 11-keto-β-boswellic acid derivatives.
Csuk R; Niesen-Barthel A; Schäfer R; Barthel A; Al-Harrasi A
Eur J Med Chem; 2015 Mar; 92():700-11. PubMed ID: 25618017
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
7. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
Li T; Fan P; Ye Y; Luo Q; Lou H
Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterisation of celastrol derivatives as potential anticancer agents.
Zhang HJ; Zhang GR; Piao HR; Quan ZS
J Enzyme Inhib Med Chem; 2017 Dec; 33(1):190-198. PubMed ID: 29231066
[TBL] [Abstract][Full Text] [Related]
10. Novel triazole hybrids of myrrhanone C, a natural polypodane triterpene: Synthesis, cytotoxic activity and cell based studies.
Chandrashekhar M; Nayak VL; Ramakrishna S; Mallavadhani UV
Eur J Med Chem; 2016 May; 114():293-307. PubMed ID: 27015609
[TBL] [Abstract][Full Text] [Related]
11. New phosphate derivatives of betulin as anticancer agents: Synthesis, crystal structure, and molecular docking study.
Chrobak E; Kadela-Tomanek M; Bębenek E; Marciniec K; Wietrzyk J; Trynda J; Pawełczak B; Kusz J; Kasperczyk J; Chodurek E; Paduszyński P; Boryczka S
Bioorg Chem; 2019 Jun; 87():613-628. PubMed ID: 30947097
[TBL] [Abstract][Full Text] [Related]
12. Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans.
Wolfram RK; Fischer L; Kluge R; Ströhl D; Al-Harrasi A; Csuk R
Eur J Med Chem; 2018 Jul; 155():869-879. PubMed ID: 29960206
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
14. Platanic acid: A new scaffold for the synthesis of cytotoxic agents.
Kahnt M; Heller L; Grabandt P; Al-Harrasi A; Csuk R
Eur J Med Chem; 2018 Jan; 143():259-265. PubMed ID: 29197730
[TBL] [Abstract][Full Text] [Related]
15. New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
Roldán-Peña JM; Alejandre-Ramos D; López Ó; Maya I; Lagunes I; Padrón JM; Peña-Altamira LE; Bartolini M; Monti B; Bolognesi ML; Fernández-Bolaños JG
Eur J Med Chem; 2017 Sep; 138():761-773. PubMed ID: 28728108
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of β-boswellic acid based HDAC inhibitors as inducers of cancer cell death.
Sharma S; Ahmad M; Bhat JA; Kumar A; Kumar M; Zargar MA; Hamid A; Shah BA
Bioorg Med Chem Lett; 2014 Oct; 24(19):4729-4734. PubMed ID: 25176189
[TBL] [Abstract][Full Text] [Related]
18. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives.
El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G
Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative properties of new hydrophilic esters of triterpenic acids.
Eignerova B; Tichy M; Krasulova J; Kvasnica M; Rarova L; Christova R; Urban M; Bednarczyk-Cwynar B; Hajduch M; Sarek J
Eur J Med Chem; 2017 Nov; 140():403-420. PubMed ID: 28987603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
